What is the appropriate liquid trimethoprim‑sulfamethoxazole (Bactrim) dose for an 8‑year‑old male with a urinary tract infection weighing 37.1 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Liquid Trimethoprim-Sulfamethoxazole Dosing for Pediatric UTI

For an 8-year-old male weighing 37.1 kg with a urinary tract infection, administer liquid trimethoprim-sulfamethoxazole at 8 mg/kg/day of the trimethoprim component (approximately 297 mg trimethoprim daily) divided into 2 doses every 12 hours for 7-10 days. 1, 2

Specific Dosing Calculation

  • Total daily dose: 8 mg/kg trimethoprim + 40 mg/kg sulfamethoxazole 1, 2
  • For 37.1 kg patient:
    • Trimethoprim: 297 mg/day (8 mg × 37.1 kg)
    • Sulfamethoxazole: 1,484 mg/day (40 mg × 37.1 kg)
  • Divided dosing: Give approximately 148.5 mg trimethoprim with 742 mg sulfamethoxazole every 12 hours 1, 2

Practical Administration

The liquid suspension typically contains 40 mg trimethoprim and 200 mg sulfamethoxazole per 5 mL. 2 For this patient, administer approximately 18.5 mL every 12 hours (which provides 148 mg trimethoprim and 740 mg sulfamethoxazole per dose). 2

Treatment Duration

Treat for 7-10 days for uncomplicated UTI. 1, 3 The Pediatrics guideline specifically recommends 7-14 days for febrile UTI in young children, with most practitioners using 7-10 days for school-age children with uncomplicated infection. 1

Important Caveats

Age Restriction

Trimethoprim-sulfamethoxazole is contraindicated in children less than 2 months of age due to risk of kernicterus. 4, 2 This 8-year-old patient is well above this threshold.

Local Resistance Patterns

Check local antibiogram data before prescribing. 1 Trimethoprim-sulfamethoxazole should only be used when local E. coli resistance rates are below 20%. 5, 6 Many regions now exceed this threshold, with resistance rates ranging from 25-34% in recent studies. 5, 7

Risk Factors for Resistance

Avoid trimethoprim-sulfamethoxazole if the patient has: 5

  • Received TMP-SMX within the past 90 days (8.77-fold increased resistance risk)
  • Recurrent UTIs (2.27-fold increased resistance risk)
  • Genitourinary abnormalities (2.31-fold increased resistance risk)

Alternative First-Line Options

If local resistance exceeds 20% or risk factors are present, consider alternative agents: 1, 3

  • Cephalexin: 25-50 mg/kg/day divided into 4 doses
  • Amoxicillin-clavulanate: 20-40 mg/kg/day (amoxicillin component) in 3 doses
  • Cefixime: 8 mg/kg/day in 1 dose
  • Cefpodoxime: 10 mg/kg/day in 2 doses

Monitoring

Obtain complete blood count at initiation and monthly if prolonged therapy is needed, as trimethoprim-sulfamethoxazole can cause hematologic toxicity including neutropenia. 8

Clinical Follow-Up

Reassess clinical response within 48-72 hours. 1 If fever persists beyond 48 hours or symptoms worsen, consider treatment failure and obtain urine culture with sensitivities to guide alternative therapy. 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.